company background image
MIRA logo

MIRA Pharmaceuticals NasdaqCM:MIRA Stock Report

Last Price

US$1.19

Market Cap

US$19.7m

7D

-7.8%

1Y

-24.7%

Updated

08 Dec, 2024

Data

Company Financials +

MIRA Pharmaceuticals, Inc.

NasdaqCM:MIRA Stock Report

Market Cap: US$19.7m

MIRA Stock Overview

Operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. More details

MIRA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

MIRA Pharmaceuticals, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for MIRA Pharmaceuticals
Historical stock prices
Current Share PriceUS$1.19
52 Week HighUS$5.01
52 Week LowUS$0.51
Beta0
11 Month Change-24.20%
3 Month Change-18.49%
1 Year Change-24.68%
33 Year Changen/a
5 Year Changen/a
Change since IPO-83.96%

Recent News & Updates

Here's Why We're Not Too Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn Situation

Nov 19
Here's Why We're Not Too Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn Situation

Recent updates

Here's Why We're Not Too Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn Situation

Nov 19
Here's Why We're Not Too Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn Situation

We're Hopeful That MIRA Pharmaceuticals (NASDAQ:MIRA) Will Use Its Cash Wisely

Jul 24
We're Hopeful That MIRA Pharmaceuticals (NASDAQ:MIRA) Will Use Its Cash Wisely

Shareholder Returns

MIRAUS PharmaceuticalsUS Market
7D-7.8%0.9%1.0%
1Y-24.7%13.4%32.4%

Return vs Industry: MIRA underperformed the US Pharmaceuticals industry which returned 13.4% over the past year.

Return vs Market: MIRA underperformed the US Market which returned 32.4% over the past year.

Price Volatility

Is MIRA's price volatile compared to industry and market?
MIRA volatility
MIRA Average Weekly Movement16.2%
Pharmaceuticals Industry Average Movement9.9%
Market Average Movement6.3%
10% most volatile stocks in US Market16.5%
10% least volatile stocks in US Market3.1%

Stable Share Price: MIRA's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: MIRA's weekly volatility has decreased from 91% to 16% over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
20205Erez Aminovmirapharmaceuticals.com

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

MIRA Pharmaceuticals, Inc. Fundamentals Summary

How do MIRA Pharmaceuticals's earnings and revenue compare to its market cap?
MIRA fundamental statistics
Market capUS$19.71m
Earnings (TTM)-US$11.24m
Revenue (TTM)n/a

0.0x

P/S Ratio

-1.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MIRA income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$11.24m
Earnings-US$11.24m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.68
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did MIRA perform over the long term?

See historical performance and comparison